doi: 10.1016/S0020-7292(99)00198-8
Given this timeline, total treatment cost remains important: 18 months of brand-name Wegovy at cash-pay pricing costs approximately $5,986, while 18 months of compounded semaglutide costs $3,582
But high-profile journals were publishing papers that downplayed or omitted my contributions
Contraindications for Wegovy WEGOVY is contraindicated in the following conditions: A personal or family history of MTC or in patients with MEN 2 [see Warnings and Precautions (5.1)]
Subsequently, other drugs such as Novos Victoza (liraglutide, approved in 2010), AstraZenecas Bydureon (exenatide, 2012), GSKs Tanzeum (albiglutide, 2014), Lillys Trulicity (dulaglutide, 2014) and Novos Ozempic (semaglutide, 2017) and Rybelsus (oral semaglutide, 2019) were approved